Systemic Lupus Erythematosus is an autoimmune disease affecting multiple organs. Symptoms include rashes, joint pain, anemia, ...

The Lupus Foundation of America (LFA) is excited to share that enrollment for the MiSLE (Mesenchymal Stromal Cells in Systemic Lupus Erythematosus) study was officially completed on February 21, 2025 ...

Discover how targeted therapies are revolutionizing autoimmune disease treatment by offering greater precision.

The Lupus Foundation of America, the national force devoted to solving the cruel mystery of lupus, announced the appointment ...

In this groundbreaking treatment for lupus, the immune system's primary defence cells known as T-cells were extracted and reprogrammed at ADSCC's advanced GMP laboratories, one of the few ...

B cells are central to both protective immunity and pathogenic autoimmunity. In systemic lupus erythematosus (SLE), aberrant B cell activation leads to the production of autoreactive antibodies ...

Learn how antibody-drug conjugates are advancing therapies for non-cancer conditions, unlocking new possibilities in ...

Supercharged ‘natural killer’ cells could become a potent way to reset a disordered immune system — and thus quench some autoimmune disorders. Results from two small clinical trials suggest ...

my research has focused on understanding the decisions immune cells make during infection and how the breakdown of these decision-making processes cause disease. My lab’s recent findings shed light on ...

“Our analysis shows that certain naturally occurring autoantibodies can tilt the odds dramatically toward shrinking tumors,” ...

Capstan Therapeutics scientists demonstrate that lipid nanoparticles can engineer CAR T cells within the body without laboratory cell manufacturing and ex vivo expansion. The method using targeted ...